We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Matthew is Chief Executive Officer and co-founder of OncoSenX, a biotech firm commercializing a breakthrough technology for killing cancerous based on their genetics. A serial entrepreneur with a background in computer security, immunology and gene therapy. Matthew was previously the founder and CEO of Immusoft, a biotech firm developing a technology that turns patients’ B cells into miniature drug factories. Matthew speaks and presents regularly to university, association and scientific audiences, including those at his alma mater, the University of Washington. He served for several years as a mentor to recipients of the Thiel Fellowship, a program that awarded grants to some of the world’s brightest scientific minds under age 20.
This speaker's sessions: